Showing results (1321-1330 of 1,382) with videos related to
Sort By:
Pageof 139
Drug Development Research|November 16, 2022
In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulationAshraf S Hassan, Nesrin M Morsy, Wael M Aboulthana, et al.Drug Development Research|February 6, 2026
Bulk Microarray and Single-Cell Transcriptomic Analyses Reveal Bacterial Lipopolysaccharide-Related Biomarkers in SepsisHaili Zhang, Xiaoying Wu, Lixue Wu, et al.Drug Development Research|February 3, 2026
Potent Multi-Target Inhibition of Cholinesterases and Carbonic Anhydrases by Iridium(III)-Phenanthroline Derivatives: Integrated Structure-Activity Relationship, Molecular Docking and Anticancer Cell Culture StudiesZeynep Köksal, Kevser Kübra Kırboğa, Fatma Sağır, et al.Drug Development Research|February 3, 2026
Antiplasmodial Activity and Pharmacokinetic Profiling of Cryptolepine and 2,7-Dibromocryptolepine With a View to Informing the Design of Novel Antimalarial Cryptolepine AnaloguesElodie Chenu, James Duffy, Arnold Donkor Forkuo, et al.Drug Development Research|January 30, 2026
Ferroptosis in Cholangiocarcinoma Therapy: Molecular Mechanisms, Pharmacological Modulation and Opportunities for Drug DevelopmentHafsa Athar, Sabahat Zulfiqar, Arslan Ali, et al.Drug Development Research|February 4, 2026
AAV9-Delivered α7nAChR Ameliorates DSS-Induced Murine Ulcerative Colitis by Activating CAP Pathway, Inhibiting NF-κB/NLRP3 Axis and Restoring Intestinal Barrier and T-reg/Th-17 HomeostasisRui Zhang, Qincheng Yang, Huimin BiDrug Development Research|June 16, 2025
β-Glucuronidase Inhibition in Drug Development: Emerging Strategies for Mitigating Drug-Induced Toxicity and Enhancing Therapeutic OutcomesAhmed A Allam, Hassan A Rudayni, Noha A Ahmed, et al.Drug Development Research|June 10, 2025
Novel Metronidazole Conjugates as Antimicrobial AgentsErol Akgün, Melike Demirayak, Leyla Yurttaş, et al.Drug Development Research|April 15, 2025
FOXA1 Targets NEK2 to Mediate Cisplatin Resistance in Lung Adenocarcinoma Cells by Activating DNA Damage RepairJunhong Yang, Guangcheng Yue, Zhiguo Fan, et al.Drug Development Research|March 27, 2025
Carboxymethyl Starch: A Contemporary Paradigm for Anti Cancer Drug DeliveryRabab FatimaPageof 139